UPDATE 1-Sanofi, Eli Lilly reach deal on insulin product

Sept 28 (Reuters) - Sanofi and Eli Lilly said they agreed to end a lawsuit over Lilly's right to market a copy of the French drugmaker's injectable insulin product in the United States.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.